349
Participants
Start Date
March 31, 2005
Primary Completion Date
March 31, 2008
Study Completion Date
March 31, 2008
Aripiprazole+ ADT
Tablets, Oral, 2 - 20 mg variable dose once daily, 14 weeks
Placebo+ ADT
Tablets, Oral, 2 - 20 mg variable dose once daily, 14 weeks
Suburban Research Associates, Media
University Of Pennsylvania, Philadelphia
Thomas Jefferson University, Philadelphia
George Washington University Medical Center, Washington D.C.
Pharmasite Research, Inc., Baltimore
University Of Virginia, Charlottesville
Behavioral Health Center, Charlotte
Usc School Of Medicine, Columbia
Southeast Health Consultants, Charleston
Carman Research, Smyrna
Medical College Of Georgia, Augusta
Cns Clinical Research Group, Coral Springs
University Of Alabama At Birmingham, Birmingham
Midwest Clinical Research Center, Dayton
Summit Research Network, Farmington Hills
Summit Research Network, Flint
Northbrooke Research Center, Brown Deer
Dean Foundation For Health Research & Education, Middleton
Regions Hospital, Saint Paul
University Of Minnesota, Minneapolis
Comprehensive Neuroscience, Inc., Hoffman Estates
Uptown Research Institute, Llc, Chicago
Cunningham Clinical Research, Llc, Edwardsville
Vine Street Clinical Research Center, Springfield
Clinical Research Institute, Witchita
Lsu Health Sciences Center, New Orleans
Phebe Tucker, Md, Oklahoma City
Community Clinical Research, Inc., Austin
Radiant Research, Slc, Salt Lake City
University Of Utah School Of Medicine, Salt Lake City
Radiant Research Las Vegas, Las Vegas
Sharp Mesa Vista Hospital, San Diego
Summit Research Network, Portland
Northwest Clinical Research Center, Bellevue
Collaborators (1)
Otsuka America Pharmaceutical
INDUSTRY
Otsuka Pharmaceutical Development & Commercialization, Inc.
INDUSTRY